source
- Virtuoso Surgical receives FDA De Novo clearance for robotic bladder lesion removal systemVirtuoso Surgical's Virtuoso Endoscopy System received FDA De Novo authorization, marking the first device in a new classification for electromechanical surgical technologies that use robotic instr…
- Gubra appoints ex-HHS official Brett Giroir as co-CEO after sudden exit of Markus RohrwildGubra, the Danish obesity partner of AbbVie and Boehringer Ingelheim, announced a leadership change following the abrupt departure of its CEO, Markus Rohrwild. The company will operate under a co…